Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Fujita

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Journal of Radiation Research|September 2, 2011
The radiotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin treatment is an effective therapeutic option in patients with advanced or metastatic bladder cancerMasaomi Ikeda, Kazumasa Matsumoto, Yuzuru Niibe, et al.
Internal Medicine (Tokyo, Japan)|February 14, 2018
The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial PneumoniasTetsuo Fujita, Takuma Hiroishi, Kohei Shikano, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 11, 2006
[Cranial nerve palsies due to skull base metastases in patients with prostate cancer: a report of two cases]Masaki Kimura, Takefumi Satoh, Tetsuo Fujita, et al.
Urology|September 13, 2011
Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsySatoru Minamida, Takefumi Satoh, Kenichi Tabata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 16, 2012
[Analysis of risk factors of drug-induced lung injury in patients receiving gemcitabine treatment]Hidenori Nakamichi, Tetsuo Fujita, Daiki Tsuji, et al.
Biomedical Research (Tokyo, Japan)|March 7, 2015
Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary bladderMorihiro Nishi, Kazumasa Matsumoto, Makoto Kobayashi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2015
High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancerHideyasu Tsumura, Kazumasa Matsumoto, Masaomi Ikeda, et al.
BJU International|December 21, 2010
A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatinKazumasa Matsumoto, Masanori Noguchi, Takefumi Satoh, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 18, 2011
[Myocardial metastasis from renal cell carcinoma treated with sorafenib]Yoshiko Tokuyama, Masatsugu Iwamura, Tetsuo Fujita, et al.
Urology|July 5, 2005
Cancer core distribution in patients diagnosed by extended transperineal prostate biopsyTakefumi Satoh, Kazumasa Matsumoto, Tetsuo Fujita, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Journal of Radiation Research|September 2, 2011
The radiotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin treatment is an effective therapeutic option in patients with advanced or metastatic bladder cancerMasaomi Ikeda, Kazumasa Matsumoto, Yuzuru Niibe, et al.
Internal Medicine (Tokyo, Japan)|February 14, 2018
The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial PneumoniasTetsuo Fujita, Takuma Hiroishi, Kohei Shikano, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 11, 2006
[Cranial nerve palsies due to skull base metastases in patients with prostate cancer: a report of two cases]Masaki Kimura, Takefumi Satoh, Tetsuo Fujita, et al.
Urology|September 13, 2011
Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsySatoru Minamida, Takefumi Satoh, Kenichi Tabata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 16, 2012
[Analysis of risk factors of drug-induced lung injury in patients receiving gemcitabine treatment]Hidenori Nakamichi, Tetsuo Fujita, Daiki Tsuji, et al.
Biomedical Research (Tokyo, Japan)|March 7, 2015
Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary bladderMorihiro Nishi, Kazumasa Matsumoto, Makoto Kobayashi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2015
High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancerHideyasu Tsumura, Kazumasa Matsumoto, Masaomi Ikeda, et al.
BJU International|December 21, 2010
A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatinKazumasa Matsumoto, Masanori Noguchi, Takefumi Satoh, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 18, 2011
[Myocardial metastasis from renal cell carcinoma treated with sorafenib]Yoshiko Tokuyama, Masatsugu Iwamura, Tetsuo Fujita, et al.
Urology|July 5, 2005
Cancer core distribution in patients diagnosed by extended transperineal prostate biopsyTakefumi Satoh, Kazumasa Matsumoto, Tetsuo Fujita, et al.
Pageof 11